Dartmouth Health Continuing Education for Professionals Home, General Internal Medicine Education Conference 2020 - Management of Hepatitis C in Primary Care 6/25/2020, 6/25/2020 8:00:00 AM - 6/25/2023 9:00:00 AM, New screening guidelines based on changing epidemiology are leading to more diagnoses of Hepatitis C and a greater need for treatment than can be met by gastrointestinal and infectious disease specialists. Newer anti-viral medications that are safer, more effective, and simpler to use make treatment in primary care practical. This presentation, together with a new Knowledge Map guideline and the assistance of a specialty pharmacy, will guide the primary care provider through treating their patient's hepatitis C in the primary care setting.
Presenters
Charles Brackett. MD, MPH
General Internal Medicine, Dartmouth-Hitchcock Medical Center
Assistant Professor of Medicine
The Dartmouth Institute and Geisel School of Medicine, Dartmouth
David De Gijsel, MD, MPH
Infectious Disease, Dartmouth-Hitchcock Medical Center
Assistant Professor of Medicine, Geisel School of Medicine, Dartmouth
Learning Outcome(s)
Participants will be able to describe the epidemiology, natural history, and treatment options of/for Hepatitis C, including a newly formulated management algorithm, and to be aware of new USPSTF screening recommendations and the rationale for treating patients in primary care.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Management of Hepatitis C in Primary Care (General Internal Medicine Education Conference 2020) have reported NO financial interest or relationship* which could be perceived as a real or apparent conflict of interest. There were no individuals in a position to control content that refused to disclose.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Presenters
Charles Brackett. MD, MPH
General Internal Medicine, Dartmouth-Hitchcock Medical Center
Assistant Professor of Medicine
The Dartmouth Institute and Geisel School of Medicine, Dartmouth
David De Gijsel, MD, MPH
Infectious Disease, Dartmouth-Hitchcock Medical Center
Assistant Professor of Medicine, Geisel School of Medicine, Dartmouth
Learning Outcome(s)
Participants will be able to describe the epidemiology, natural history, and treatment options of/for Hepatitis C, including a newly formulated management algorithm, and to be aware of new USPSTF screening recommendations and the rationale for treating patients in primary care.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Management of Hepatitis C in Primary Care (General Internal Medicine Education Conference 2020) have reported NO financial interest or relationship* which could be perceived as a real or apparent conflict of interest. There were no individuals in a position to control content that refused to disclose.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
